MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
Abstract Background Chemotherapeutic agents that modulate cell cycle checkpoints and/or tumor-specific pathways have shown immense promise in preclinical and clinical studies aimed at anti-cancer therapy. MASTL (Greatwall in Xenopus and Drosophila), a serine/threonine kinase controls the final G2/M...
Guardat en:
| Autors principals: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2018-08-01
|
| Col·lecció: | Molecular Cancer |
| Matèries: | |
| Accés en línia: | http://link.springer.com/article/10.1186/s12943-018-0848-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
